Wala ray nanduruman paraan na panagtambal ed prostate cancer, depende ed stage tan kakapuyan na kanser, ontan met ed bunigas na pasyente tan personal ya labay to.
Arum ed saray kaslakan a panagtambal et:
1. Aktibon panbantay: Sayan paraan et mangilalanor ed maapit a panbantay ed kanser panamegley na regular a panag-check-up tan panag-eksamin, imbes ya igapo a tampol so panagtambal.
Nayarin matukoy itan ed saray lalakin walaan na prostate cancer a daiset so posibilidad ya ontubo.
2. Surgery: Say prostatectomy et sakey a proseso na operasyon pian ekalen so prostate gland.
Nagawa itan panamegley na open surgery odino laparoscopically (pangusar ed angkelag iran sugat tan espisyal iran kagawaan).
3. Radiation therapy: Uusaren ed sayan paraan so high-energy radiation pian pateyen iray selula na kanser.
Nayari itan ya ipa-abort ed paway (manlapud makina ya walad paway na laman) odino diad loob (diad panamegley na implant ya inyan ed asingger na tumor).
4. Hormone therapy: Sayan panagtambal et mamapabeba ed saray laki ya hormone (androgen) ed laman, a nayarin mamakepa odino mamatunda ed ibaleg na prostate cancer.
Nayari itan ya usaren a bukor odino kaiba na arum nin panagtambal.
5. Chemotherapy: Sayan panagtambal et uusaren iray druga pian pateyen iray selula na kanser.
Nayarin usaren itan ed advanced ya prostate cancer ya kinmayat ed arum a parte na laman.
6. Immunotherapy: Ontulong iyan panagtambal ed immune system pian nalabanan so kanser.
Nayarin usaren itan ed advanced prostate cancer ya ag-inmabig ed arum a panagtambal.
7. Targeted therapy: Sayan panagtambal et i-target toy espisipikon genes odino protina ya ontutulong ed ibabaleg tan panbilay na saray selula na kanser.
Nayarin usaren itan ed advanced prostate cancer ya ag-inmabig ed arum a panagtambal.
8. Cryotherapy: Sayan panagtambal et manguusar na graben betel pian pakelawen tan pateyen iray selula na kanser.
Nayarin usaren itan ed kanser ed prostate ya onggagapo ni labat odino diad kanser ya ompapawil kayari na arum a panagtambal.
9. High-intensity focused ultrasound (HIFU): Uusaren na sayan paraan so high-frequency sound waves pian papetangen tan deralen iray selula na kanser.
Nayarin usaren itan ed kanser ed prostate ya onggagapo ni labat odino diad kanser ya ompapawil kayari na arum a panagtambal.
10. Watchful waiting: Sayan paraan et mangilalanor ed maapit a pangobserba ed kanser panamegley na regular a panag-eksamin, balet agnigapo so panagtambal likud labat no wala la ray sintomas odino anguman la iratan.
Nayarin matukoy itan ed saray mas matatken a lalaki a walaan na matantan ya ombabaleg a kanser ed prostate tan arum niran seryoson kondisyon ed bunigas.
Importante ya pantongtongan so amin a paraan na panagtambal a nayarin gawaen na doktor pian naamtaan no dinan so sankaabigan a paraan ed kada situasyon.
Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.
Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.
Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.
Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.
Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.
['Disclaimer: medikal']
['Sayan website et parad edukasyon tan impormasyon labat tan agmangiter na medikal a simbawa odino propesyonal a serbisyo.']
['Say impormasyon ya intarya so agnepeg ya usaren pian nadiagnose odino natambal so problema ed bunigas odino sakit, tan saramay manaanap na personal a medikal a simbawa so nepeg a mankonsulta ed sakey a lisensiadon doktor.']
['Tandaan ya say neural network ya uusaren pian naebatan iray tepet et aliwan susto no bilang so usaren, singa bilang na totoon walay sakit da.']
['Lawas onkerew na simbawa ed doktor odino arum nin kualipikadon health provider nipaakar ed sakit mo. Agmon balot ibabaliwala so simbawa na doktor odino itutunda itan lapud walay abasam ed sayan website. No iisipen mon walay emergency mo, tawagan so 911 odino onla kan tampol ed sankaasinggeran ya emergency room.']
['Disclaimer: copyright']
['Say Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (say DMCA) et mangiiter na legal a tulong ed saray akankayarian na copyright no manisia ran say materyal ya walad Internet et onkokontra ed kanepegan da. ']
['No manisia ka ya walay karga odino materyal ya in-post ed website odino diad saray serbisyo mi ya onkokontra ed copyright mo, sarag mo (odino say representative mo) ya ipawit ed sikami so sakey a sulat ya mangibagan ekalen mi so karga odino materyal, odino i-block so access ed satan. ']
['Saray anunsio et nepeg ya ipawit ed sulat panamegley na e-mail (nengnengen so "Contact" section parad e-mail address). ']
['Unong ed DMCA, kaukolan ya ipila ed pakabat mo so onggendan ya impormasyon: (1) deskripsion na copyrighted ya kimey ya ibabagan inabuso; (2) deskripsion na ibabagan inabuso tan impormasyon ya magenap pian naromog mi itan; (3) impormasyon pian nakontak ka, kaiba lay address, numero na telepono, tan email address mo; (4) deklarasyon mo ya talagan papanisiaan mon say inusar mo et ag-inabuloyan na akankayaryan na copyright, odino na ahente to, odino na anggan anton ley; ']
['(5) sakey a deklarasyon ya pinirmaan mo, ya agmo aabuloyan ya palso so ibabaga na satan, ya susto so impormasyon ed samay inyanunsio tan walay autoridad mon mangipaakseb ed saray copyright ya ibabagan asakitan; ']
['tan (6) sakey a pisikal odino electronic signature na akankayarian na copyright odino sakey a toon naikdan na autoridad ya onkiwas parad akankayarian na copyright. ']
['No agmo ipila so amin ya impormasyon ed tagey, nayarin naabala so pangasikaso ed reklamo mo.']
['Kontak']
['Ipangasin ipawit ed sikami so antokaman a tepet / suhestion yo.']
How to treat prostate cancer?
There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.
Some common treatments include:
1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.
It may be suitable for men with low-risk prostate cancer.
2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.
It can be done through open surgery or laparoscopically (using small incisions and specialized tools).
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).
4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.
It can be used alone or in combination with other treatments.
5. Chemotherapy: This treatment uses drugs to kill cancer cells.
It may be used for advanced prostate cancer that has spread to other parts of the body.
6. Immunotherapy: This treatment helps the immune system fight cancer.
It may be used for advanced prostate cancer that has not responded to other treatments.
7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.
It may be used for advanced prostate cancer that has not responded to other treatments.
8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.
It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.
It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Nipaakar ed']
['Uusaren na BioMedLib iray automated computer (machine-learning algorithms) pian makapanggaway parepareho iran tepet tan ebat.']
['Igapo tayo ed 35 milyon ya biomedical ya publikasyon na PubMed/Medline.']
